-
WATCH THE INTERVIEW
Val Romberg, CEO of Kedrion Biopharma, explains how our company is working on cultural change, and efficiency and business program improvements.
Watch the interview online on "Le Fonti TV". -
Keep life flowing
Kedrion’s plasma-derived therapies help people suffering from rare diseases like Hemophilia and Primary Immune Deficiencies. We are privileged to provide this service and do so with a profound sense of responsibility.
-
Keep life flowing
Kedrion’s plasma-derived therapies help people suffering from rare diseases like Hemophilia and Primary Immune Deficiencies. We are privileged to provide this service and do so with a profound sense of responsibility.
You are now leaving this website.
Are you sure?
Are you sure?
NO
YES
News
CORPORATE
First Patient Enrolled in KIDCARES10
Kedrion Biopharma Pediatric Primary Immunodeficiency Study
read moreCORPORATE
Kedrion Biopharma Phase III Trial, CARES10, achieves important milestone: Last Patient Treated
Last Patient Treated
read more
Where 